These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 12662271

  • 1. Transfusion medicine illustrated: an unusual plasmapheresis product.
    Danielson C, Skipworth E, Jackson L, Houseworth J, McCarthy L.
    Transfusion; 2003 Apr; 43(4):421. PubMed ID: 12662271
    [No Abstract] [Full Text] [Related]

  • 2. Management of the idiopathic nephrotic syndrome.
    Glassock RJ.
    Contrib Nephrol; 1980 Apr; 23():158-80. PubMed ID: 7002448
    [No Abstract] [Full Text] [Related]

  • 3. [Generalized edema in a young woman. Why is she losing proteins?].
    Stiefelhagen P.
    MMW Fortschr Med; 2013 Mar 07; 155(4):20. PubMed ID: 23614185
    [No Abstract] [Full Text] [Related]

  • 4. [Nephrotic syndrome in minimal change disease (kidney), focal segmental glomerulosclerosis, and focal mesangioproliferative glomerulonephritis].
    Voznesenskaia TS, Sergeeva TV.
    Ter Arkh; 2002 Mar 07; 74(6):31-3. PubMed ID: 12136479
    [Abstract] [Full Text] [Related]

  • 5. IgM-associated mesangial proliferative glomerulonephritis and focal and segmental hyalinosis with nephrotic syndrome.
    Aubert J, Humair L, Chatelanat F, de Torrenté A.
    Am J Nephrol; 1985 Mar 07; 5(6):445-9. PubMed ID: 4083317
    [Abstract] [Full Text] [Related]

  • 6. Renal disease. II. The treatment of minimal change nephropathy and focal segmental glomerulosclerosis.
    Mason PD.
    J R Coll Physicians Lond; 1997 Mar 07; 31(2):137-41. PubMed ID: 9131509
    [No Abstract] [Full Text] [Related]

  • 7. [Treatment of primary glomerulonephritis].
    Nagy J.
    Orv Hetil; 2005 Jan 23; 146(4):169-73. PubMed ID: 15751512
    [No Abstract] [Full Text] [Related]

  • 8. [Cell-mediated immunity in the pathogenesis of the nephrotic syndrome caused by glomerulopathy with minimal histological lesions].
    Zucchelli P, Cagnoli L.
    Minerva Nefrol; 1982 Jan 23; 29(1):3-10. PubMed ID: 7099481
    [No Abstract] [Full Text] [Related]

  • 9. [Use of plasmapheresis in children with nephrotic syndrome].
    Enikeeva ZM, Beliaev SE, Kudinov VI, Sakaeva IM, Khasanova ASh.
    Pediatriia; 1991 Jan 23; (7):94-6. PubMed ID: 1836558
    [No Abstract] [Full Text] [Related]

  • 10. Cyclosporine in nephrotic syndrome.
    Ponticelli C, Rivolta E.
    Transplant Proc; 1988 Jun 23; 20(3 Suppl 4):253-8. PubMed ID: 3289208
    [No Abstract] [Full Text] [Related]

  • 11. Nephrotic syndrome in childhood. Management and treatment in patients with minimal change disease, mesangial proliferation, or focal glomerulosclerosis.
    McEnery PT, Strife CF.
    Pediatr Clin North Am; 1982 Aug 23; 29(4):875-94. PubMed ID: 7050865
    [No Abstract] [Full Text] [Related]

  • 12. [Nephrotic syndrome: therapeutic possibilities].
    Gans RO.
    Ned Tijdschr Geneeskd; 1991 Dec 14; 135(50):2375-9. PubMed ID: 1749442
    [No Abstract] [Full Text] [Related]

  • 13. [Pathogenesis of the idiopathic nephrotic syndrome].
    Robeva R.
    Vutr Boles; 1988 Dec 14; 27(5):9-14. PubMed ID: 3062902
    [No Abstract] [Full Text] [Related]

  • 14. Cyclosporine treatment of nephrotic syndrome in children.
    Brodehl J, Hoyer PF, Oemar BS, Helmchen U, Wonigeit K.
    Transplant Proc; 1988 Jun 14; 20(3 Suppl 4):269-74. PubMed ID: 3381282
    [No Abstract] [Full Text] [Related]

  • 15. [Nephrotic syndrome. Physiopathology, diagnosis, development, treatment of lipoid nephrosis].
    Chabannier MH, Modesto A, Orfila C, Suc JM.
    Rev Prat; 1996 Oct 01; 46(15):1907-15. PubMed ID: 8953847
    [No Abstract] [Full Text] [Related]

  • 16. Hemolytic uremic syndrome and crescentic glomerulonephritis complicating childhood nephrosis.
    Krensky AM, Ingelfinger JR, Grupe WE, Rosen S.
    Clin Nephrol; 1983 Feb 01; 19(2):99-106. PubMed ID: 6839557
    [Abstract] [Full Text] [Related]

  • 17. Relapsing Guillain Barré Syndrome and nephrotic syndrome secondary to focal segmental glomerulosclerosis.
    Souayah N, Cros D, Stein TD, Chong PS.
    J Neurol Sci; 2008 Jul 15; 270(1-2):184-8. PubMed ID: 18325535
    [Abstract] [Full Text] [Related]

  • 18. An update on LDL apheresis for nephrotic syndrome.
    Raina R, Krishnappa V.
    Pediatr Nephrol; 2019 Oct 15; 34(10):1655-1669. PubMed ID: 30218191
    [Abstract] [Full Text] [Related]

  • 19. [Blood lipid disorders in the nephrotic syndrome. Physiopathological aspects and therapeutic prospects].
    Campanacci L.
    Minerva Med; 1976 Sep 30; 67(46):2951-60. PubMed ID: 787832
    [No Abstract] [Full Text] [Related]

  • 20. Cyclosporin A in steroid-sensitive nephrotic syndrome with frequent relapses.
    Chan MK, Cheng IK.
    Postgrad Med J; 1987 Sep 30; 63(743):757-9. PubMed ID: 3444800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.